Enhanced passive safety surveillance of a trivalent and a quadrivalent influenza vaccine in Denmark and Finland during the 2018/2019 season

The European Medicines Agency requires Enhanced Passive Safety Surveillance (EPSS) for all seasonal influenza vaccines. Here, we report the EPSS results for the trivalent inactivated influenza vaccine (IIV3; Vaxigrip®) and the quadrivalent inactivated influenza vaccine (IIV4; VaxigripTetraTM) during...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Laurence Serradell, Sophie Wagué, Annick Moureau, Markku Nissilä, Anne-Laure Chabanon
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Taylor & Francis Group 2021-04-01
Schriftenreihe:	Human Vaccines & Immunotherapeutics
Schlagworte:	influenza vaccines vaccination safety safety surveillance seasonal influenza adverse reaction adverse event reactogenicity immunization
Online-Zugang:	http://dx.doi.org/10.1080/21645515.2020.1804247
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!